Medical treatments will be most effective whenever they are able to re-establish natural physiological processes. Such curative approaches demand much more complex biological products than the traditional small molecules resulting from chemical synthesis.
Obtaining such safe products with enhanced biocompatibility is one of iBET’s main objectives. With a great number of projects in the area of complex biopharmaceuticals and innovative treatments, completed or still underway, iBET has considerable experience working with the pharmaceutical industry and R&D consortia.
